Trial Information

Summary: Effect of NT-proBNP guided treatment of Chronic Heart Failure (PRIMA Study).

Status: No longer recruiting

Protocol Number: 2003 B131

Sponsor:

Company Division: Diagnostic

Official Scientific Title: Can pro-brain natriuretic peptide guided therapy of chronic heart failure improve heart failure morbidity and mortality?

Brief Summary: This study will determine whether NT-proBNP guided treatment of chronic congestive heart failure to an individually pre-defined target value will reduce heart failure-related morbidity and mortality compared to therapy guided by standard clinical judgement.

Study Phase: N/A

Study Design / Study Details:

• Purpose:
• Allocation: Randomized
• Masking: Open Label
• Control:
• Assignment: Parallel
• Endpoints:

Study Type:

Condition: Congestive Heart Failure

Intervention Type: Diagnostic Test

Intervention Name: ELECSYS®proBNP

Primary Outcome:

Key Secondary Outcomes:

Inclusion Criteria:

Exclusion Criteria:

Gender: Males or Females

Age Limits: Min: 18 Years

Accepts Healthy Volunteers: No

Anticipated Start Date: May, 2004

Trial Registration Date: 08/22/2007

Date Last Updated: 02/07/2008

Link To Trial Results

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: September 2, 2008 at 1:53:36 PM